Image For Activity Cover
Encouraging Results Seen in Patients with Heavily Pre-Treated Low-Grade Serous Ovarian
Description

Listen to Dr. Rachel Grisham as she shares results from her IGCS 2023 late-breaking presentation from Seoul. Abstract will be available on Sunday, November 5 on igcsmeeting.com.

Recording available Wednesday, November 8, 2023
Duration approximately 20 minutes

Attended previous IGCS webinars? If you have attended IGCS webinars in the past, you may already have an IGCS account and creating a new account is not required. If unsure of your login information, you may reset your information by selecting "Forgot Password" at login or contact education@igcs.org.

If you have questions or need assistance, contact education@igcs.org

Faculty Information

Rachel Grisham, MD
Section Head Ovarian Cancer
Director, Gynecologic Medical Oncology
Memorial Sloan Kettering Cancer Center
USA

Dr. Rachel Grisham is an Associate Attending within the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSKCC) and Associate Professor of Medicine at Weill Cornell Medical College.  She is the Section Head of Ovarian Cancer Treatment and the Director of Gynecologic Medical Oncology at MSKCC Westchester. She is board certified in Medical Oncology and received her Medical Degree at Duke University School of Medicine. Dr. Grisham performed her Internal Medicine Internship and Residency at Massachusetts General Hospital.  She then came to Memorial Sloan Kettering Cancer Center where she served as the Chief Fellow of the Hematology and Oncology Fellowship Program. Dr. Grisham subsequently joined the Gynecologic Medical Oncology Service in 2012. Dr. Grisham’s research focuses on determining the molecular drivers of low-grade serous ovarian cancer and the development of targeted treatment strategies for patients with recurrent ovarian cancer. She has served as the principal investigator for over 25 clinical trials and serves on multiple committees within ASCO, NRG and SGO. She is a graduate of the ASCO leadership development program, and has served on the GOG Partners Investigators Council, NRG Rare Tumor Committee, NCCN Ovarian Cancer Guidelines Committee, and the ASCO Annual Meeting Scientific Program Committee. Dr. Grisham is the recipient of an ASCO Merit Award, a Conquer Cancer Career Development Award, an Ovarian Cancer Research Fund Liz Tilberis Award, Kaleidoscope of Hope Grants, multiple Cycle for Survival Grants, and a Translational and Integrative Medicine Research Fund Grant.

Wendel Naumann, MD 
Moderator
Director of Minimally Invasive Surgery in Gynecologic Oncology  

Carolinas Medical Center Associate Medical Director of Clinical Trials 
Associate Medical Director of Clinical Trials 
Levine Cancer Institute, Atrium Health 
USA 

 

Supported in part by
Summary
Availability: On-Demand
Cost: FREE
Recommended
Contact education@igcs.org for assistance.
Powered By